| Literature DB >> 30683053 |
Samiullah Khan1,2, Shu-Biao Wu3, Juliet Roberts1.
Abstract
BACKGROUND: Eggshell formation takes place in the shell gland of the oviduct of laying hens. The eggshell is rich in calcium and various glycoproteins synthesised in the shell gland. Although studies have identified genes involved in eggshell formation, little is known about the regulation of genes in the shell gland particularly in a temporal manner. The current study investigated the global gene expression profile of the shell gland of laying hens at different time-points of eggshell formation using RNA-Sequencing (RNA-Seq) analysis.Entities:
Keywords: Chicken oviduct; Eggshell formation; Gene regulation; Ions transport; Matrix proteins; Transcriptome profiling
Mesh:
Year: 2019 PMID: 30683053 PMCID: PMC6347800 DOI: 10.1186/s12864-019-5460-4
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Schematic diagram explaining the selection of samples for RNA-Seq and differentially expressed genes (DEGs) data analysis. To validate the results of RNA-Seq, qPCR was performed on all 40 RNA samples and the data were analysed in qbase+ software for gene expression study. For bioinformatics analysis, the 5 h time-point was taken as the reference control as compared to the 15 h time-point
Candidate target and reference* genes in expression studies by qPCR in the shell gland of laying hens
| Gene Name | Gene Symbol | Primer sequence (5′-3′) | Amplicon size (bp) | Ta °C | PCR Efficiency (%) | Accession No. | Reference |
|---|---|---|---|---|---|---|---|
| Secreted phosphoprotein 1 |
| F-CCAGGAAGCTCATTGAGGATG | 134 | 60 | 101 | NM_204535.4 | This study |
| Proopiomelanocortin |
| F-TGGTGTTTTGGCGTGTGC | 115 | 65 | 105 | NM_001031098.1 | This study |
| Calbindin |
| F: TTGGCACTGAAATCCCACTGA | 116 | 60 | 100 | NM_205513.1 | [ |
| Claudin 16 |
| F- TACCTTGCTCATTGCAGGTCT | 186 | 63 | 105 | XM_426702.3 | This study |
| G protein subunit gamma 4 |
| F- CAGACCAATGCACAAGTTTCA | 243 | 63 | 97 | XM_004935468.2 | This study |
| Potassium voltage-gated channel subfamily H member 1 |
| F- AGAGGCAGAGATCCAGACGA | 160 | 63 | 93 | XM_015283863.1 | This study |
| BPI fold containing family B, member 3 |
| F- CCATGCAACAAGTGCTGTCC | 234 | 63 | 94 | NM_001030861 | This study |
| Rho related BTB domain containing 3 |
| F- GACGTCGCATCTGTGATCC | 171 | 63 | 95 | ENSGALG00000014675 | This study |
| Somatostatin II |
| F- GCTCTTGGAGAGCTCAGACG | 160 | 65 | 97 | NM_204455.1 | This study |
| Otopetrin 2 |
| F- GGAGCAAGCAATTGCCCAAA | 202 | 63 | 99 | XM_003642368.3 | This study |
| Klotho beta |
| F- GAGCAATACGGGGGATGGAA | 224 | 61 | 101 | XM_003641245.3 | This study |
| Glycoprotein hormones, alpha polypeptide |
| F- GTCCAGAGTGCAAGCTAGGG | 166 | 63 | 105 | :NM_001278021 | This study |
| GATA-binding factor 3 |
| F- CAGAAGGCAGGGAGTGTGTAA | 157 | 63 | 100 | NM_001008444 | This study |
| TYRO3 protein tyrosine kinase |
| F- GTGCAGTGCAGCAATGAGAT | 186 | 61 | 98 | NM_204627 | This study |
| Matrix metallopeptidase 13 |
| F- AGCTCTATGGTGCTGGAGAC | 128 | 63 | 100 | NM_001293090 | This study |
| Gap junction protein, alpha 8 |
| F- CTGCTATGATGAGGCCTTCC | 186 | 63 | 98 | NM_204997.1 | This study |
| Carbonic anhydrase 9 |
| F- CTCAGTGACAGCAGCAGGA | 80 | 63 | 99 | XM_004937157.2 | This study |
| Cytochrome P450 family 7 subfamily A member 1 |
| F- AGGAGGCAATGAGGCTATCG | 171 | 63 | 96 | NM_001001753.1 | This study |
| Galactose-3-O-sulfotransferase |
| F- TGCTTCGAGGACTACCAAAAA | 177 | 61 | 96 | NM_001277431.1 | This study |
| TATA-Box Binding Protein |
| F: TAGCCCGATGATGCCGTAT | 147 | 61 | 97 | NM_205103 | [ |
| Tyrosine 3-monooxygenase/tryptophan |
| F- TTGCTGCTGGAGATGACAAG | 61 | 60 | 104 | NM_001031343.1 | [ |
The candidate target genes were selected from the DEGs either down- or up-regulated at the 15 h relative to the 5 h time-point of eggshell formation
Sequence quality and alignment information of 12 shell gland samples in two groups (G1 and G2)
| Sample name | Total reads | Number of reads mapped to chicken genome | Percentage of reads mapped to chicken genome | Number of reads mapped to one feature | Percentage of reads mapped to one feature | Number of mapped reads not mapped to any feature | Percentage of total reads that mapped to the genome but not to any known features |
|---|---|---|---|---|---|---|---|
| G1a | 23,419,963 | 18,942,266 | 80.88% | 12,137,770 | 51.83% | 5,855,006 | 25.00% |
| G1b | 22,633,784 | 18,410,799 | 81.34% | 11,944,759 | 52.77% | 5,541,424 | 24.48% |
| G1c | 22,478,580 | 18,055,302 | 80.32% | 11,646,051 | 51.81% | 5,503,560 | 24.48% |
| G1d | 21,759,465 | 17,607,983 | 80.92% | 11,461,812 | 52.68% | 5,268,439 | 24.21% |
| G1e | 22,657,131 | 18,480,220 | 81.56% | 12,031,069 | 53.10% | 5,536,020 | 24.43% |
| G1f | 21,832,656 | 17,675,184 | 80.96% | 11,615,956 | 53.20% | 5,182,041 | 23.74% |
| G2a | 21,033,600 | 17,095,487 | 81.28% | 11,393,823 | 54.17% | 4,839,852 | 23.01% |
| G2b | 20,845,746 | 16,707,543 | 80.15% | 11,030,858 | 52.92% | 4,836,757 | 23.20% |
| G2c | 20,784,865 | 16,624,745 | 79.98% | 11,034,132 | 53.09% | 4,745,972 | 22.83% |
| G2d | 21,073,856 | 17,140,851 | 81.34% | 11,265,366 | 53.46% | 5,021,572 | 23.83% |
| G2e | 21,309,212 | 17,398,557 | 81.65% | 11,516,521 | 54.04% | 5,014,414 | 23.53% |
| G2f | 21,828,196 | 17,648,497 | 80.85% | 11,763,767 | 53.89% | 4,986,438 | 22.84% |
There were 6 shell gland samples (a-f) in each individual group. G1 and G2 refer to shell gland tissue samples obtained at 5 and 15 h time-points of eggshell formation, respectively
Top 50 down-regulated DEGs at 15 h relative to 5 h time-point
| Gene symbol | Gene name | Fold change | FDR |
|---|---|---|---|
|
| Solute carrier family 13 member 5 | −6.516 | 1.99E-07 |
|
| Klotho beta | −5.998 | 0.00079 |
|
| XIAP associated factor 1 | −5.316 | 9.26E-05 |
|
| Fin bud initiation factor homolog (zebrafish) | −4.894 | 1.40E-07 |
|
| Protein O-linked mannose N-acetylglucosaminyltransferase 1 (Beta 1,2-) | −4.828 | 0.00026 |
|
| Matrix metallopeptidase 13 | −4.673 | 0.00089 |
|
| Catenin alpha 3 | −4.625 | 0.00239 |
|
| Gap junction protein alpha 8 | −4.522 | 0.00089 |
|
| Carbonic anhydrase 9 | −4.519 | 0.00042 |
|
| Hyaluronan binding protein 2 | −4.464 | 0.00119 |
|
| Rho GTPase-activating protein 25 | −4.284 | 1.18E-06 |
|
| Semaphorin 3G | −4.254 | 3.39E-06 |
|
| Fibrinogen beta chain | −4.199 | 0.00057 |
|
| Cytochrome P450 family 7 subfamily A member 1 | −4.170 | 0.00081 |
|
| ADP-ribosylhydrolase like 1 | − 4.103 | 0.00035 |
|
| Growth hormone releasing hormone receptor | −4.075 | 0.0037 |
|
| Transcription elongation regulator 1 like | −3.925 | 4.38E-05 |
|
| FRAS1 related extracellular matrix protein 2 | − 3.835 | 0.00608 |
|
| Nuclear receptor subfamily 1, group D, member 1 | −3.785 | 0.00235 |
|
| Envoplakin | −3.749 | 1.20E-05 |
|
| Teneurin transmembrane protein 1 | −3.732 | 0.00339 |
|
| DNA nucleotidylexotransferase | 3.714 | 0.00241 |
|
| Sterile alpha motif domain containing 7 | −3.620 | 0.00405 |
|
| Hyaluronan synthase 2 | −3.564 | 0.00034 |
|
| Poly (RC) binding protein 2 | −3.548 | 0.00125 |
|
| Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 | −3.545 | 4.48E-05 |
|
| Adrenoceptor alpha 2A | −3.512 | 0.00042 |
|
| Chromobox 2 | −3.484 | 0.00497 |
|
| Tumor necrosis factor superfamily member 10 | −3.475 | 5.95E-05 |
|
| Solute carrier family 26 member 4 | −3.467 | 0.03297 |
|
| Netrin 1 | −3.449 | 0.01807 |
|
| Von Willebrand Factor | −3.448 | 0.00591 |
|
| Cytosolic phospholipase A2 epsilon-like | −3.409 | 0.03367 |
|
| DAB1, reelin adaptor protein | −3.383 | 0.00025 |
|
| Family with sequence similarity 159 member A | −3.347 | 0.00295 |
|
| APC membrane recruitment protein 2 | − 3.299 | 0.00011 |
|
| Glutaredoxin and cysteine rich domain containing 1 | −3.205 | 0.05005 |
|
| Breast carcinoma amplified sequence 1 | − 3.197 | 0.0048 |
|
| Solute carrier family 13 member 2 | −3.162 | 2.00E-05 |
|
| Neurofibromin 2 (merlin)-like | −3.111 | 0.00156 |
|
| Glycoprotein hormones, alpha polypeptide | −3.078 | 0.01157 |
|
| Complement C8 beta chain | −3.063 | 0.01559 |
|
| Synaptotagmin 15 | −3.055 | 0.00329 |
|
| Ras related dexamethasone induced 1 | −3.047 | 5.25E-06 |
|
| Potassium voltage-gated channel subfamily A member 1 | −3.045 | 0.01937 |
|
| GATA-binding factor 3 | −3.036 | 1.18E-06 |
|
| Phospholipase A2 group IVF | −3.029 | 0.03613 |
|
| Sarcalumenin | −2.959 | 0.00252 |
|
| Desmocollin 2 | −2.954 | 0.00012 |
|
| Anoctamin-3 isoform 1 | − 2.933 | 0.00307 |
Fold change (FC) was calculated in log2 value. Minus (−) sign shows down-regulation of the genes at the 15 h relative to the 5 h time-point
Top 50 up-regulated DEGs at 15 h relative to 5 h time-point
| Gene symbol | Gene name | Fold change | FDR |
|---|---|---|---|
|
| Proopiomelanocortin | + 9.179 | 0.0005 |
|
| Calbindin | + 8.081 | 3E-08 |
|
| Secreted phosphoprotein 1 | + 7.993 | 2E-07 |
|
| Neuraminidase 4 | + 7.682 | 0.0021 |
|
| Cell migration inducing hyaluronan binding protein | + 7.555 | 9E-06 |
|
| Galactose-3-O-sulfotransferase 2 | + 6.999 | 0.0005 |
|
| Solute carrier family 6 member 17 | + 6.643 | 0.0271 |
|
| G protein subunit gamma 4 | + 6.586 | 0.0416 |
|
| BPI fold containing family B, member 3 | + 6.414 | 3E-06 |
|
| Endothelin converting enzyme Like 1 | + 6.408 | 0.0312 |
|
| Regenerating family member 4 | + 6.272 | 0.0017 |
|
| Angiopoietin like 3 | + 6.199 | 0.0002 |
|
| Transmembrane protein 2-like | + 6.062 | 6E-06 |
|
| Potassium voltage-gated channel, subfamily H (eag-related), member 1 | + 5.956 | 0.0009 |
|
| gonadotropin-releasing hormone receptor | + 5.949 | 0.0122 |
|
| Marker of proliferation Ki-67 | + 5.815 | 0.0127 |
|
| Bactericidal/permeability-increasing protein-like 3 | + 5.250 | 0.0004 |
|
| Solute carrier family 29 member 4 | + 5.183 | 8E-05 |
|
| Wnt family member 11 | + 4.799 | 4E-05 |
|
| Chordin | + 4.691 | 3E-05 |
|
| Orofacial cleft 1 candidate gene 1 protein homolog | + 4.330 | 0.0005 |
|
| G Protein-coupled receptor 183 | + 4.329 | 0.0001 |
|
| ETS variant 4 | + 4.309 | 0.0264 |
|
| Rho related BTB domain containing 3 | + 4.305 | 0.0036 |
|
| Otopetrin 2 | + 4.226 | 1E-05 |
|
| Major facilitator superfamily domain containing 13A | + 4.190 | 2E-08 |
|
| TNF receptor superfamily member 6b | + 4.182 | 0.0005 |
|
| Phospholipid phosphatase related 4 | + 4.161 | 8E-05 |
|
| BetaGal beta-1,3-N-acetylglucosaminyltransferase 7 | + 4.139 | 9E-05 |
|
| Semaphorin 3D | + 4.126 | 0.0206 |
|
| Family with sequence similarity 163 member A | + 4.125 | 0.004 |
|
| RUN and cysteine rich domain containing beclin 1 interacting protein like | + 4.049 | 1E-06 |
|
| Otopetrin 3 | + 4.003 | 0.0014 |
|
| Basic helix-loop-helix family member a15 | + 3.998 | 0.0354 |
|
| Solute carrier family 38 member 8 | + 3.941 | 0.0013 |
|
| Tubulin beta 3 class III | + 3.924 | 0.0002 |
|
| Ethanolamine kinase 1 | + 3.918 | 4E-06 |
|
| Gga-mir-6556 | + 3.913 | 0.0017 |
|
| PPARGC1 and ESRR induced regulator, muscle 1 | + 3.902 | 0.007 |
|
| Collagen type XXI alpha 1 chain | + 3.885 | 0.0003 |
|
| Neuronal pentraxin 1 | + 3.884 | 0.0106 |
|
| Epiregulin | + 3.867 | 0.0434 |
|
| Fatty acid binding protein 3 | + 3.824 | 4E-05 |
|
| Somatostatin II | + 3.804 | 0.0062 |
|
| Phosphoglycerate dehydrogenase | + 3.777 | 0.0004 |
|
| Hepatic and glial cell adhesion molecule | + 3.751 | 0.0055 |
|
| Mitogen-activated protein kinase kinase kinase 15 | + 3.737 | 1E-05 |
|
| WSC domain containing 2 | + 3.716 | 6E-07 |
|
| Na+/K+ transporting ATPase interacting 1 | + 3.694 | 0.0038 |
|
| Pleiotrophin | + 3.693 | 0.0016 |
Fold change (FC) was calculated in log2 value. Plus (+) sign shows up-regulation of the genes at 15 h relative to 5 h time-point
Putative functions of mRNA sequences that did not annotate to any known gene IDs during Ensembl annotations of RNA-Seq transcripts
| Group | Sequence ID | Gene ID | Associated GO term | Fold change | FDR |
|---|---|---|---|---|---|
| aG1 | ENSGALG00000039411 |
| Heparin binding and beta-amyloid binding | − 4.899 | 0.0031 |
| ENSGALG00000032113 |
| N-acetyltransferase activity and aspartate N-acetyltransferase activity | − 4.038 | 9E-05 | |
| ENSGALG00000029321 |
| N-acetyltransferase activity and aspartate N-acetyltransferase activity | − 3.857 | 0.0009 | |
| ENSGALG00000030322 |
| No associated GO term found | − 3.349 | 0.0003 | |
| ENSGALG00000038759 |
| No associated GO term found | − 2.867 | 0.0007 | |
| bG2 | ENSGALG00000037163 |
| Protein homodimerization activity and Rab GTPase binding | + 6.402 | 0.0004 |
| ENSGALG00000006393 |
| G-protein coupled receptor activity and transmembrane signaling receptor activity | + 5.243 | 0.0306 | |
| ENSGALG00000039812 |
| G-protein coupled receptor activity and sphingosine-1-phosphate receptor activity | + 5.154 | 0.0014 | |
| ENSGALG00000029410 |
| Transcription factor activity, sequence-specific DNA binding and RNA polymerase II core promoter proximal region sequence-specific DNA binding | + 4.578 | 0.0031 | |
| ENSGALG00000041414 |
| Protein homodimerization activity and RNA polymerase II core promoter proximal region sequence-specific DNA binding | + 4.419 | 0.0003 | |
| ENSGALG00000042845 |
| 3,5-cyclic-nucleotide phosphodiesterase activity and 3,5-cyclic-AMP phosphodiesterase activity | + 3.885 | 0.0039 | |
| ENSGALG00000035935 |
| Diacylglycerol binding | + 3.701 | 7E-06 | |
| ENSGALG00000033066 |
| Ligase activity and acid-amino acid ligase activity | + 3.672 | 0.0166 | |
| ENSGALG00000033883 |
| Calcium ion binding | + 3.125 | 0.0042 | |
| ENSGALG00000031565 |
| RNA polymerase II core promoter sequence-specific DNA binding | + 3.005 | 0.0399 | |
| ENSGALG00000037545 |
| Protein C-terminus binding and receptor signaling complex scaffold activity | + 2.937 | 0.0009 | |
| ENSGALG00000008047 |
| Ligase activity and ubiquitin protein ligase activity | + 2.903 | 0.0216 | |
| ENSGALG00000011860 |
| Actin binding and actin filament binding | + 2.596 | 0.0036 | |
| ENSGALG00000042801 |
| Hydrolase activity and 5-nucleotidase activity | + 2.396 | 0.0298 | |
| ENSGALG00000039716 |
| Calcium ion binding and actin binding | + 2.304 | 1E-05 | |
| ENSGALG00000041604 |
| No associated GO term found | + 2.295 | 0.0051 | |
| ENSGALG00000030673 |
| NADH dehydrogenase (ubiquinone) activity | + 2.096 | 0.0076 | |
| ENSGALG00000042104 |
| Identical protein binding and LRR domain binding | + 2.044 | 0.0119 | |
| ENSGALG00000038532 |
| Actin binding and SH3 domain binding | + 1.878 | 0.0086 | |
| ENSGALG00000038993 |
| No associated GO term found | + 1.842 | 3E-06 | |
| ENSGALG00000041238 |
| Receptor activity | + 1.798 | 3E-05 | |
| ENSGALG00000042411 |
| No associated GO term found | + 1.765 | 0.0009 | |
| ENSGALG00000043703 |
| Extracellular matrix structural constituent and extracellular matrix constituent conferring elasticity | + 1.630 | 0.0034 | |
| ENSGALG00000043198 |
| Metallopeptidase activity and aminopeptidase activity | + 1.609 | 0.0021 | |
| ENSGALG00000043209 |
| G-protein coupled receptor activity and transmembrane signaling receptor activity | + 1.573 | 0.0267 |
To retrieve the best homology hit, the sequence IDs were blasted against chicken, duck, turkey and human reference genomes in Ensembl BLAT database. The cut off criterion was established as e-value <10E− 20. aRepresents genes significantly (log2 fold change > 1.5; FDR < 0.05) down-regulated at the 15 h relative to the 5 h time-point. bRepresents genes significantly up-regulated at the 15 h relative to the 5 h time-point
Fig. 2Functional map of DEGs (log2 fold change > 1.5; FDR < 0.05) enriched for GO terms specific for biological process, cellular component and molecular function. The chart fragments represent the number of genes associated with the terms as a proportion with the total number of genes within the GO term. a GO terms associated with genes significantly down-regulated at the 15 h relative to the 5 h time-point of eggshell formation. b GO terms associated with genes significantly up-regulated at the 15 h relative to the 5 h time-point of eggshell formation. **P < 0.001 and *P < 0.01 show the level of significance of the enriched terms
Fig. 3Network representation of the enriched GO terms and their associated genes obtained from the mapping of down-regulated genes at the 15 h relative to the 5 h time-point. The GO terms were identified as nodes and linked based on their p-value < 0.05 and kappa score level (> 0.4). Functionally related groups partially overlapped. The terms are labelled in colours according to hierarchical clustering of GO terms. Terms which have not been grouped are shown in grey
Fig. 4Network representation of the enriched GO terms and their associated genes obtained from the mapping of up-regulated genes at the 15 h relative to the 5 h time-point. The GO terms were identified as nodes and linked based on their p-value < 0.05 and kappa score level (> 0.4). Functionally related groups partially overlapped. The terms are labelled in colours according to hierarchical clustering of GO terms. Terms which have not been grouped are shown in grey
Fig. 5Hierarchical clustering analysis of the top 50 DEGs significantly down- or up-regulated at the 15 h relative to the 5 h time-point. a Top 50 DEGs significantly down-regulated at the 15 h relative to the 5 h time-point. b Top 50 DEGs significantly up-regulated at the 15 h relative to the 5 h time-point. G1a-f represent six samples taken at the 5 h time-point, while G1a-f represent six samples taken at the 15 h time-point of eggshell formation
Fig. 6DNA gel electrophoresis of the qPCR products showing that the primers were specific in amplification. Panel a: L) DNA ladder; 1) GAL3ST2 (177 bp); 2) CYP7A1 (171 bp); 3) CALB1 (116 bp); 4) TYRO3 (186 bp); 5) CNG4 (243 bp); 6) POMC (115 bp); 7) RHOBTB3 (171 bp); 8) KCNH1 (160 bp); 9) MMP13 (128 bp); 10) KLB (224 bp); 11) GATA3 (157 bp); 12) SPP1 (134 bp). Panel b: L) DNA ladder; 1) YWHAZ (61 bp); 2) TBP (147 bp); 3) IBV T-as positive control (181 bp); 4) CA9 (80 bp); 5) OTOP2 (202 bp); 6) CGA (166 bp); 7) CLDN16 (186 bp); 8) GJA8 (186 bp); 9) SS2 (160 bp); 10) BPIFB3 (234 bp); 11) PPARGCIB-Positive control (82 bp); 12) TLR3-Positive control (203 bp). The upper (purple) and lower markers (green) act as internal standards and are used to align the ladder analysis with the individual DNA sample analysis. The DNA gel in Agilent 2100 Bioanalyzer was performed as per the manufacturer’s instructions of Agilent DNA 1000 Kit. The size of the individual amplicons are consistent with the expected size
Comparison of the gene expression data between RNA-Seq and qPCR
| Gene | Fold change | |
|---|---|---|
| qPCR | RNA-Seq | |
|
| −2.335 | −3.078 |
|
| −10.374 | − 4.170 |
|
| −7.331 | −3.036 |
|
| −19.366 | −4.522 |
|
| −4.320 | −4.673 |
|
| −4.249 | −1.942 |
|
| −10.377 | −4.519 |
|
| −38.019 | −5.998 |
|
| + 5.427 | + 6.586 |
|
| + 32.199 | + 5.956 |
|
| + 30.038 | + 6.414 |
|
| + 316.268 | + 9.179 |
|
| + 306.140 | + 7.993 |
|
| + 68.867 | + 6.999 |
|
| + 12.366 | + 4.226 |
|
| + 74.817 | + 8.081 |
|
| + 13.025 | + 5.434 |
|
| + 5.378 | + 3.212 |
|
| + 14.644 | + 4.305 |
For qPCR, the relative expression level of genes at the 5 h and 15 h time-points was calculated in qbase+ software based on 2^-ΔΔCq with genes amplification specific efficiency. For gene expression data normalisation, TBP and YWHAZ were used as reference genes. Plus and minus signs show down- or up-regulation of genes at the 15 h relative to the 5 h time-point